FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3089783249> ?p ?o ?g. }

• W3089783249 abstract "Cumulative studies have shown that RNA binding proteins (RBPs) play an important role in numerous malignant tumors and are related to the occurrence and progression of tumors. However, the role of RBPs in kidney renal clear cell carcinoma (KIRC) is not fully understood. In this study, we first downloaded gene expression data and corresponding clinical information of KIRC from the Cancer Genome Atlas (TCGA) database, International Cancer Genome Consortium (ICGC), and Gene Expression Omnibus (GEO) database, respectively. A total of 137 differentially expressed RBPs (DERBPs) were then identified between normal and tumor tissue, including 38 downregulated and 99 upregulated RBPs. Nine RBPs (EIF4A1, RPL36A, EXOSC5, RPL28, RPL13, RPS19, RPS2, EEF1A2, and OASL) were served as prognostic genes and exploited to construct a prognostic model through survival analysis. Kaplan-Meier curves analysis showed that the low-risk group had a better survival outcome when compared with the high-risk group. The area under the curve (AUC) value of the prognostic model was 0.713 in the TCGA data set (training data set), 0.706 in the ICGC data set, and 0.687 in the GSE29609 data set, respectively, confirming a good prognostic model. The prognostic model was also identified as an independent prognostic factor for KIRC survival by performing cox regression analysis. In addition, we also built a nomogram relying on age and the prognostic model and internal validation in the TCGA data set. The clinical benefit of the prognostic model was revealed by decision curve analysis (DCA). Gene set enrichment analysis revealed several crucial pathways (ERBB signaling pathway, pathways in cancer, MTOR signaling pathway, WNT signaling pathway, and TGF BETA signaling pathway) that may explain the underlying mechanisms of KIRC. Furthermore, potential drugs for KIRC treatment were predicted by the Connectivity Map (Cmap) database based on DERBPs, including several important drugs, such as depudecin and vorinostat, that could reverse KIRC gene expression, which may provide reference for the treatment of KIRC. In summary, we developed and validated a robust nine-RBP signature for KIRC prognosis prediction. A nomogram with risk score and age can be applied to promote the individualized prediction of overall survival in patients with KIRC. Moreover, the two drugs depudecin and vorinostat may contribute to KIRC treatment." @default.
• W3089783249 created "2020-10-08" @default.
• W3089783249 creator A5012565337 @default.
• W3089783249 creator A5021002082 @default.
• W3089783249 creator A5051411280 @default.
• W3089783249 creator A5056699783 @default.
• W3089783249 creator A5062284808 @default.
• W3089783249 creator A5076160343 @default.
• W3089783249 creator A5081513163 @default.
• W3089783249 creator A5088609184 @default.
• W3089783249 creator A5088621169 @default.
• W3089783249 creator A5091155587 @default.
• W3089783249 date "2020-10-02" @default.
• W3089783249 modified "2023-09-29" @default.
• W3089783249 title "Development and Validation of Nine-RNA Binding Protein Signature Predicting Overall Survival for Kidney Renal Clear Cell Carcinoma" @default.
• W3089783249 cites W1974710541 @default.
• W3089783249 cites W1997535872 @default.
• W3089783249 cites W2019900735 @default.
• W3089783249 cites W2032630062 @default.
• W3089783249 cites W2035618305 @default.
• W3089783249 cites W2045030989 @default.
• W3089783249 cites W2049003194 @default.
• W3089783249 cites W2082139701 @default.
• W3089783249 cites W2090786177 @default.
• W3089783249 cites W2091415498 @default.
• W3089783249 cites W2114104545 @default.
• W3089783249 cites W2114621872 @default.
• W3089783249 cites W2121604817 @default.
• W3089783249 cites W2132840768 @default.
• W3089783249 cites W2143996748 @default.
• W3089783249 cites W2155142785 @default.
• W3089783249 cites W2170552969 @default.
• W3089783249 cites W2233456601 @default.
• W3089783249 cites W2412000512 @default.
• W3089783249 cites W2560219063 @default.
• W3089783249 cites W2570362976 @default.
• W3089783249 cites W2586242098 @default.
• W3089783249 cites W2589774246 @default.
• W3089783249 cites W2598348504 @default.
• W3089783249 cites W2600408715 @default.
• W3089783249 cites W2621219284 @default.
• W3089783249 cites W2790875654 @default.
• W3089783249 cites W2807109438 @default.
• W3089783249 cites W2898704476 @default.
• W3089783249 cites W2900569176 @default.
• W3089783249 cites W2902167640 @default.
• W3089783249 cites W2902406306 @default.
• W3089783249 cites W2913256160 @default.
• W3089783249 cites W2957529709 @default.
• W3089783249 cites W2972090205 @default.
• W3089783249 cites W2972751266 @default.
• W3089783249 cites W2986355235 @default.
• W3089783249 cites W2998747012 @default.
• W3089783249 cites W3007324275 @default.
• W3089783249 cites W3010839018 @default.
• W3089783249 doi "https://doi.org/10.3389/fgene.2020.568192" @default.
• W3089783249 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7566920" @default.
• W3089783249 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33133154" @default.
• W3089783249 hasPublicationYear "2020" @default.
• W3089783249 type Work @default.
• W3089783249 sameAs 3089783249 @default.
• W3089783249 citedByCount "12" @default.
• W3089783249 countsByYear W30897832492021 @default.
• W3089783249 countsByYear W30897832492022 @default.
• W3089783249 countsByYear W30897832492023 @default.
• W3089783249 crossrefType "journal-article" @default.
• W3089783249 hasAuthorship W3089783249A5012565337 @default.
• W3089783249 hasAuthorship W3089783249A5021002082 @default.
• W3089783249 hasAuthorship W3089783249A5051411280 @default.
• W3089783249 hasAuthorship W3089783249A5056699783 @default.
• W3089783249 hasAuthorship W3089783249A5062284808 @default.
• W3089783249 hasAuthorship W3089783249A5076160343 @default.
• W3089783249 hasAuthorship W3089783249A5081513163 @default.
• W3089783249 hasAuthorship W3089783249A5088609184 @default.
• W3089783249 hasAuthorship W3089783249A5088621169 @default.
• W3089783249 hasAuthorship W3089783249A5091155587 @default.
• W3089783249 hasBestOaLocation W30897832491 @default.
• W3089783249 hasConcept C104317684 @default.
• W3089783249 hasConcept C10515644 @default.
• W3089783249 hasConcept C126322002 @default.
• W3089783249 hasConcept C143998085 @default.
• W3089783249 hasConcept C158163496 @default.
• W3089783249 hasConcept C2777472916 @default.
• W3089783249 hasConcept C2781068499 @default.
• W3089783249 hasConcept C34626388 @default.
• W3089783249 hasConcept C50382708 @default.
• W3089783249 hasConcept C54355233 @default.
• W3089783249 hasConcept C6856738 @default.
• W3089783249 hasConcept C70721500 @default.
• W3089783249 hasConcept C71924100 @default.
• W3089783249 hasConcept C86803240 @default.
• W3089783249 hasConceptScore W3089783249C104317684 @default.
• W3089783249 hasConceptScore W3089783249C10515644 @default.
• W3089783249 hasConceptScore W3089783249C126322002 @default.
• W3089783249 hasConceptScore W3089783249C143998085 @default.
• W3089783249 hasConceptScore W3089783249C158163496 @default.
• W3089783249 hasConceptScore W3089783249C2777472916 @default.
• W3089783249 hasConceptScore W3089783249C2781068499 @default.
• W3089783249 hasConceptScore W3089783249C34626388 @default.
• W3089783249 hasConceptScore W3089783249C50382708 @default.

• next